Cargando…

Difunctional bacteriophage conjugated with photosensitizers for Candida albicans-targeting photodynamic inactivation

BACKGROUND: Candida albicans is the most prevalent fungal pathogen of the human microbiota, causing infections ranging from superficial infections of the skin to life-threatening systemic infections. Due to the increasing occurrence of antibiotic-resistant C. albicans strains, new approaches to cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Shuai, Shi, Hongxi, Zhang, Xintong, Chen, Xi, Cao, Donghui, Mao, Chuanbin, Gao, Xiang, Wang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903486/
https://www.ncbi.nlm.nih.gov/pubmed/29692614
http://dx.doi.org/10.2147/IJN.S156815
_version_ 1783314948514906112
author Dong, Shuai
Shi, Hongxi
Zhang, Xintong
Chen, Xi
Cao, Donghui
Mao, Chuanbin
Gao, Xiang
Wang, Li
author_facet Dong, Shuai
Shi, Hongxi
Zhang, Xintong
Chen, Xi
Cao, Donghui
Mao, Chuanbin
Gao, Xiang
Wang, Li
author_sort Dong, Shuai
collection PubMed
description BACKGROUND: Candida albicans is the most prevalent fungal pathogen of the human microbiota, causing infections ranging from superficial infections of the skin to life-threatening systemic infections. Due to the increasing occurrence of antibiotic-resistant C. albicans strains, new approaches to control this pathogen are needed. Photodynamic inactivation is an emerging alternative to treat infections based on the interactions between visible light and photosensitisers, in which pheophorbide a (PPA) is a chlorophyll-based photosensitizer that could induce cell death after light irradiation. Due to PPA’s phototoxicity and low efficiency, the main challenge is to implement photosensitizer cell targeting and attacking. METHODS: In this study, PPA was conjugated with JM-phage by EDC/NHS crosslinking. UV-Vis spectra was used to determine the optimum conjugation percentages of PPA and JM-phage complex for photodynamic inactivation. After photodynamic inactivation, the efficacy of PPA-JM-phage was assessed by performing in vitro experiments, such as MTS assay, scanning electron microscopy, measurement of dysfunctional mitochondria, ROS accumulation, S cell arrest and apoptotic pathway. RESULTS: A single-chain variable-fragment phage (JM) with high affinity to MP65 was screened from human single-fold single-chain variable-fragment libraries and designed as a binding target for C. albicans cells. Subsequently, PPa was integrated into JM phage to generate a combined nanoscale material, which was called PPA-JM-phage. After photodynamic inactivation, the growth of C. albicans was inhibited by PPA-JM-phage and apoptosis was observed. Scanning electron microscopy analysis revealed shrinking and rupturing of C. albicans. We also found that depolarization of mitochondrial membrane potential was decreased and intracellular reactive oxygen species levels were elevated significantly in C. albicans inhibited by PPA-JM-phage. Additionally, PPA-JM-phage also lead to S-phase arrest, and metacaspase activation resulting from mitochondrial dysfunction was also found to be involved in C. albicans apoptosis. CONCLUSION: PPa-JM-phage may induce C. albicans apoptosis through a caspase-dependent pathway and the results herein shed light on the potential application of phtototherapeutic nanostructures in fungal inactivation.
format Online
Article
Text
id pubmed-5903486
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-59034862018-04-24 Difunctional bacteriophage conjugated with photosensitizers for Candida albicans-targeting photodynamic inactivation Dong, Shuai Shi, Hongxi Zhang, Xintong Chen, Xi Cao, Donghui Mao, Chuanbin Gao, Xiang Wang, Li Int J Nanomedicine Original Research BACKGROUND: Candida albicans is the most prevalent fungal pathogen of the human microbiota, causing infections ranging from superficial infections of the skin to life-threatening systemic infections. Due to the increasing occurrence of antibiotic-resistant C. albicans strains, new approaches to control this pathogen are needed. Photodynamic inactivation is an emerging alternative to treat infections based on the interactions between visible light and photosensitisers, in which pheophorbide a (PPA) is a chlorophyll-based photosensitizer that could induce cell death after light irradiation. Due to PPA’s phototoxicity and low efficiency, the main challenge is to implement photosensitizer cell targeting and attacking. METHODS: In this study, PPA was conjugated with JM-phage by EDC/NHS crosslinking. UV-Vis spectra was used to determine the optimum conjugation percentages of PPA and JM-phage complex for photodynamic inactivation. After photodynamic inactivation, the efficacy of PPA-JM-phage was assessed by performing in vitro experiments, such as MTS assay, scanning electron microscopy, measurement of dysfunctional mitochondria, ROS accumulation, S cell arrest and apoptotic pathway. RESULTS: A single-chain variable-fragment phage (JM) with high affinity to MP65 was screened from human single-fold single-chain variable-fragment libraries and designed as a binding target for C. albicans cells. Subsequently, PPa was integrated into JM phage to generate a combined nanoscale material, which was called PPA-JM-phage. After photodynamic inactivation, the growth of C. albicans was inhibited by PPA-JM-phage and apoptosis was observed. Scanning electron microscopy analysis revealed shrinking and rupturing of C. albicans. We also found that depolarization of mitochondrial membrane potential was decreased and intracellular reactive oxygen species levels were elevated significantly in C. albicans inhibited by PPA-JM-phage. Additionally, PPA-JM-phage also lead to S-phase arrest, and metacaspase activation resulting from mitochondrial dysfunction was also found to be involved in C. albicans apoptosis. CONCLUSION: PPa-JM-phage may induce C. albicans apoptosis through a caspase-dependent pathway and the results herein shed light on the potential application of phtototherapeutic nanostructures in fungal inactivation. Dove Medical Press 2018-04-11 /pmc/articles/PMC5903486/ /pubmed/29692614 http://dx.doi.org/10.2147/IJN.S156815 Text en © 2018 Dong et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Dong, Shuai
Shi, Hongxi
Zhang, Xintong
Chen, Xi
Cao, Donghui
Mao, Chuanbin
Gao, Xiang
Wang, Li
Difunctional bacteriophage conjugated with photosensitizers for Candida albicans-targeting photodynamic inactivation
title Difunctional bacteriophage conjugated with photosensitizers for Candida albicans-targeting photodynamic inactivation
title_full Difunctional bacteriophage conjugated with photosensitizers for Candida albicans-targeting photodynamic inactivation
title_fullStr Difunctional bacteriophage conjugated with photosensitizers for Candida albicans-targeting photodynamic inactivation
title_full_unstemmed Difunctional bacteriophage conjugated with photosensitizers for Candida albicans-targeting photodynamic inactivation
title_short Difunctional bacteriophage conjugated with photosensitizers for Candida albicans-targeting photodynamic inactivation
title_sort difunctional bacteriophage conjugated with photosensitizers for candida albicans-targeting photodynamic inactivation
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903486/
https://www.ncbi.nlm.nih.gov/pubmed/29692614
http://dx.doi.org/10.2147/IJN.S156815
work_keys_str_mv AT dongshuai difunctionalbacteriophageconjugatedwithphotosensitizersforcandidaalbicanstargetingphotodynamicinactivation
AT shihongxi difunctionalbacteriophageconjugatedwithphotosensitizersforcandidaalbicanstargetingphotodynamicinactivation
AT zhangxintong difunctionalbacteriophageconjugatedwithphotosensitizersforcandidaalbicanstargetingphotodynamicinactivation
AT chenxi difunctionalbacteriophageconjugatedwithphotosensitizersforcandidaalbicanstargetingphotodynamicinactivation
AT caodonghui difunctionalbacteriophageconjugatedwithphotosensitizersforcandidaalbicanstargetingphotodynamicinactivation
AT maochuanbin difunctionalbacteriophageconjugatedwithphotosensitizersforcandidaalbicanstargetingphotodynamicinactivation
AT gaoxiang difunctionalbacteriophageconjugatedwithphotosensitizersforcandidaalbicanstargetingphotodynamicinactivation
AT wangli difunctionalbacteriophageconjugatedwithphotosensitizersforcandidaalbicanstargetingphotodynamicinactivation